Betamethasone oral minipulse therapy an option in oral lichen planus
NEW YORK (Reuters Health), Apr 29 – Patients with symptomatic oral lichen planus respond equally well to betamethasone oral minipulse therapy and to topical triamcinolone acetonide, but they may respond more quickly to betamethasone, results of a randomized comparative study indicate. Betamethasone oral minipulse therapy “may be a useful and convenient alternative either as a monotherapy or to achieve rapid symptomatic relief during periods of exacerbations,” the study team concludes

